Skip to main content

Table 5 Mean (± SD) cTnI-value (ng/mL) in the Pimobendan- and placebo-group before and after exercise

From: Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, double-blinded trial

cTnI

Pimobendan-group

Placebo-group

before exercise

after exercise

before exercise

after exercise

day 0

0.022 (± 0.037)

0.051 (± 0.041)

0.1 (± 0.014)

0.116 (± 0.015)

day 90

0.039 (± 0.032)

0.048 (± 0.038)

0.049 (± 0.037)

0.057 (± 0.041)

day 180

0.038 (± 0.028)

0.041 (± 0.036)

0.051 (± 0.048)

0.068 (± 0.065)

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us